Tag Archives: BIO

PG Economics Report Shows GM Crops to Increase Environmental Sustainability

admin-ajax

In a recent press release, BIO’s Cathy Enright calls attention to the recently published PG Economics report, “GM Crops:  Global Socio-Economic and Environmental Impacts 1996-2012”. The economic benefits for farmers who use genetically modified (GM) seeds amounted to an average of more than $117/hectare in 2012, according to the PG Economics report. Farmers around the world who use seeds improved with biotechnology are benefiting economically while improving the environmental sustainability of their farming operations. “Half of the Read More >

Food And Agriculture  |  1 Comment  |  Email This Post
Tags: , , , , , ,

All Things Considered – “Synthetic Biology”

Rina_Singh_115x76

CQ Researcher examines the pros/cons to utilizing synthetic biology CQ Researcher’s April 2014 article, Synthetic Biology: Should Scientists Try to Create New Life Forms, delves into the benefits and hesitations of using synthetic biology to create new or improved medicines, fuels and other innovative products. The pro/con piece within the article showcases a debate between BIO‘s own Dr. Rina Singh, Senior Director, Industrial and Environmental and Jaydee Hanson, Senior Policy Analyst, Center for Food Safety, and Policy Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Joins Partners for Healthy Dialogues

Jim Greenwood

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had the opportunity to ask Jim Greenwood, President and CEO of BIO, about why BIO joined the effort, the importance of collaboration and preparing for the Physician Payments Sunshine Act. “BIO and our members support transparency in the life science industry and in the relationships between industry and physicians. We also strongly believe in the value of such relationships for the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent Docs Highlights the BIO IPDx Symposium

shutterstock_10020697

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and Diagnostics Symposium (IPDx).  Moderated by Donald Zuhn at MBHB, panelists from MBHB, Roche Diagnostics, and the USPTO discussed the impact of the Myriad decision on obtaining patent protection for genetic diagnostics.  The panel concluded the following: “While there was agreement that the Myriad holding is not limited to human DNA, there was spirited disagreement regarding its long-term impact on patents claiming naturally Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

New BIO Survey on Effective FDA – Sponsor Communication During Drug Development

BIO Logo Horizontal 4C copy

BIO is surveying members on their interactions with the FDA during the various stages of drug development prior to submitting an NDA/BLA. The survey can be accessed here. In an increasingly competitive and fiscally-constrained environment, it is more important than ever for all stakeholders to work together to promote effective R&D for innovative medicines. This initial survey is designed to assist in the implementation of the Prescription Drug User Fee Act (PDUFA V) program on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,